Germany, France, Italy and Spain will resume using the Oxford/AstraZeneca coronavirus vaccine
Europe’s biggest countries are set to resume using the Oxford/AstraZeneca coronavirus vaccine after the EU drugs regulator said the jab was safe, and the US is taking a tough stance as members from the Biden administration meet with Chinese officials in Alaska. Plus, the FT’s markets editor, Katie Martin, explains why investors are reboarding airline stocks.
EU drugs regulator backs ‘safe and effective’ AstraZeneca vaccine
US signals tough stance ahead of first meeting with China
Airlines tap stock and bond markets as they prepare for surge in bookings
See acast.com/privacy for privacy and opt-out information.
A transcript for this podcast is currently unavailable, view our accessibility guide.
Get alerts on FT News Briefing when a new story is published